352 related articles for article (PubMed ID: 17135988)
1. Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).
Curry J; Rohde P; Simons A; Silva S; Vitiello B; Kratochvil C; Reinecke M; Feeny N; Wells K; Pathak S; Weller E; Rosenberg D; Kennard B; Robins M; Ginsburg G; March J;
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1427-39. PubMed ID: 17135988
[TBL] [Abstract][Full Text] [Related]
2. Symptom clusters in adolescent depression and differential response to treatment: a secondary analysis of the Treatment for Adolescents with Depression Study randomised trial.
Bondar J; Caye A; Chekroud AM; Kieling C
Lancet Psychiatry; 2020 Apr; 7(4):337-343. PubMed ID: 32199509
[TBL] [Abstract][Full Text] [Related]
3. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.
March JS; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J
Arch Gen Psychiatry; 2007 Oct; 64(10):1132-43. PubMed ID: 17909125
[TBL] [Abstract][Full Text] [Related]
4. The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks.
March J; Silva S; Vitiello B;
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1393-403. PubMed ID: 17135984
[TBL] [Abstract][Full Text] [Related]
5. Trajectories of Symptom Change in the Treatment for Adolescents With Depression Study.
Scott K; Lewis CC; Marti CN
J Am Acad Child Adolesc Psychiatry; 2019 Mar; 58(3):319-328. PubMed ID: 30768414
[TBL] [Abstract][Full Text] [Related]
6. Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS).
Vitiello B; Rohde P; Silva S; Wells K; Casat C; Waslick B; Simons A; Reinecke M; Weller E; Kratochvil C; Walkup J; Pathak S; Robins M; March J;
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1419-26. PubMed ID: 17135987
[TBL] [Abstract][Full Text] [Related]
7. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
March J; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J;
JAMA; 2004 Aug; 292(7):807-20. PubMed ID: 15315995
[TBL] [Abstract][Full Text] [Related]
8. Moderators and Predictors of Response After 36 Weeks of Treatment in the Treatment for Adolescents with Depression Study (TADS).
O'Dor SL; Washburn J; Howard KR; Reinecke MA
Res Child Adolesc Psychopathol; 2021 Nov; 49(11):1489-1501. PubMed ID: 34050856
[TBL] [Abstract][Full Text] [Related]
9. Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS).
Kennard B; Silva S; Vitiello B; Curry J; Kratochvil C; Simons A; Hughes J; Feeny N; Weller E; Sweeney M; Reinecke M; Pathak S; Ginsburg G; Emslie G; March J;
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1404-11. PubMed ID: 17135985
[TBL] [Abstract][Full Text] [Related]
10. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
[TBL] [Abstract][Full Text] [Related]
11. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
Davey CG; Chanen AM; Hetrick SE; Cotton SM; Ratheesh A; Amminger GP; Koutsogiannis J; Phelan M; Mullen E; Harrison BJ; Rice S; Parker AG; Dean OM; Weller A; Kerr M; Quinn AL; Catania L; Kazantzis N; McGorry PD; Berk M
Lancet Psychiatry; 2019 Sep; 6(9):735-744. PubMed ID: 31371212
[TBL] [Abstract][Full Text] [Related]
12. Acute time to response in the Treatment for Adolescents with Depression Study (TADS).
Kratochvil C; Emslie G; Silva S; McNulty S; Walkup J; Curry J; Reinecke M; Vitiello B; Rohde P; Feeny N; Casat C; Pathak S; Weller E; May D; Mayes T; Robins M; March J;
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1412-8. PubMed ID: 17135986
[TBL] [Abstract][Full Text] [Related]
13. Research knowledge among the participants in the Treatment for Adolescents With Depression Study (TADS).
Vitiello B; Kratochvil CJ; Silva S; Curry J; Reinecke M; Pathak S; Waslick B; Hughes CW; Prentice ED; May DE; March JS
J Am Acad Child Adolesc Psychiatry; 2007 Dec; 46(12):1642-50. PubMed ID: 18030086
[TBL] [Abstract][Full Text] [Related]
14. An exploratory analysis of the impact of family functioning on treatment for depression in adolescents.
Feeny NC; Silva SG; Reinecke MA; McNulty S; Findling RL; Rohde P; Curry JF; Ginsburg GS; Kratochvil CJ; Pathak SM; May DE; Kennard BD; Simons AD; Wells KC; Robins M; Rosenberg D; March JS
J Clin Child Adolesc Psychol; 2009 Nov; 38(6):814-25. PubMed ID: 20183665
[TBL] [Abstract][Full Text] [Related]
15. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.
Brent D; Emslie G; Clarke G; Wagner KD; Asarnow JR; Keller M; Vitiello B; Ritz L; Iyengar S; Abebe K; Birmaher B; Ryan N; Kennard B; Hughes C; DeBar L; McCracken J; Strober M; Suddath R; Spirito A; Leonard H; Melhem N; Porta G; Onorato M; Zelazny J
JAMA; 2008 Feb; 299(8):901-913. PubMed ID: 18314433
[TBL] [Abstract][Full Text] [Related]
16. Treatment for Adolescents with Depression Study (TADS): safety results.
Emslie G; Kratochvil C; Vitiello B; Silva S; Mayes T; McNulty S; Weller E; Waslick B; Casat C; Walkup J; Pathak S; Rohde P; Posner K; March J; ;
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1440-55. PubMed ID: 17135989
[TBL] [Abstract][Full Text] [Related]
17. Treatment response in depressed adolescents with and without co-morbid attention-deficit/hyperactivity disorder in the Treatment for Adolescents with Depression Study.
Kratochvil CJ; May DE; Silva SG; Madaan V; Puumala SE; Curry JF; Walkup J; Kepley H; Vitiello B; March JS
J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):519-27. PubMed ID: 19877976
[TBL] [Abstract][Full Text] [Related]
18. Predictors and Moderators of Relapse in Children and Adolescents With Major Depressive Disorder.
Kennard BD; Mayes TL; Chahal Z; Nakonezny PA; Moorehead A; Emslie GJ
J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29474007
[TBL] [Abstract][Full Text] [Related]
19. Assessment of safety and long-term outcomes of initial treatment with placebo in TADS.
Kennard BD; Silva SG; Mayes TL; Rohde P; Hughes JL; Vitiello B; Kratochvil CJ; Curry JF; Emslie GJ; Reinecke MA; March JS;
Am J Psychiatry; 2009 Mar; 166(3):337-44. PubMed ID: 19147693
[TBL] [Abstract][Full Text] [Related]
20. Suicidal events in the Treatment for Adolescents With Depression Study (TADS).
Vitiello B; Silva SG; Rohde P; Kratochvil CJ; Kennard BD; Reinecke MA; Mayes TL; Posner K; May DE; March JS
J Clin Psychiatry; 2009 Apr; 70(5):741-7. PubMed ID: 19552869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
